Treating chronic hepatitis C in recovering opiate addicts: yes, we can.

Kreek, M J; Talal, A H; Piccolo, P

Kreek, M J; Talal, A H; Piccolo, P.

Affiliation

Kreek MJ; The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA. kreek@rockefeller.edu

Dig Liver Dis ; 41(4): 308-10, 2009 Apr.

Article in En | MEDLINE | ID: mdl-19233749

Subject(s)

Antiviral Agents/therapeutic use; Hepatitis C, Chronic/drug therapy; Narcotics/therapeutic use; Substance Abuse, Intravenous/complications; Substance Abuse, Intravenous/rehabilitation; Buprenorphine/therapeutic use; Drug Therapy, Combination; Drug Users; Hepatitis C, Chronic/complications; Humans; Interferon alpha-2; Interferon-alpha/therapeutic use; Italy; Methadone/therapeutic use; Patient Compliance; Polyethylene Glycols/therapeutic use; Practice Guidelines as Topic; Practice Patterns, Physicians'; Recombinant Proteins; Refusal to Treat; Ribavirin/therapeutic use; Treatment Outcome; United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Substance Abuse, Intravenous / Hepatitis C, Chronic / Narcotics Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: Dig Liver Dis Journal subject: GASTROENTEROLOGIA Year: 2009 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google